A new form of brain stimulation treatment that responds to a patient’s brain activity could be life changing for people with neurological and psychiatric disorders.
Out of all of our print and
online news coverage, we have picked five stories that we feel illustrate some high points and show how ddn is unique in reporting industry news
It’s
the phone call or e-mail that every publication editor dreads. It comes seconds before deadline time, as the content your editorial team has worked for the
last month to produce is committed to print. It comes from a writer whose story has morphed so materially from its original state that it can’t run as
planned—usually leaving a black hole in your layout to be filled at the eleventh hour.
Way too many people in the United States still don’t know what personalized medicine is, and that’s a problem we need to overcome before the misinformation creeps in too much
There’s a facelift for ddn
beginning in December, and some new directions for coverage going into 2013. With regard to that and more, the magazine’s chief editor, Amy Swinderman, walks
you through some of the highlights of the past year and what’s in store for the future
One of the aspects of drug discovery that holds tremendous promise for creating better activity profiles--molecular modeling--received a leg up recently when scientists from the Florida campus of The Scripps Research Institute (TSRI) published a paper describing improvements they have made to the methods involved in generating computer models of molecules
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.